OA10491A - Erythromycin a 9-0-oxime derivatives endowed with antibiotic activity - Google Patents

Erythromycin a 9-0-oxime derivatives endowed with antibiotic activity Download PDF

Info

Publication number
OA10491A
OA10491A OA70023A OA70023A OA10491A OA 10491 A OA10491 A OA 10491A OA 70023 A OA70023 A OA 70023A OA 70023 A OA70023 A OA 70023A OA 10491 A OA10491 A OA 10491A
Authority
OA
OAPI
Prior art keywords
erythromycin
formula
compounds
oxime
compound
Prior art date
Application number
OA70023A
Other languages
English (en)
Inventor
Franco Pellacini
Giovanna Schioppacassi
Enrico Albini
Daniela Botta
Stefano Romagnano
Francesco Santangelo
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Publication of OA10491A publication Critical patent/OA10491A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
OA70023A 1994-12-13 1997-06-13 Erythromycin a 9-0-oxime derivatives endowed with antibiotic activity OA10491A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT94MI002496A IT1276901B1 (it) 1994-12-13 1994-12-13 Derivati dell'eritromicina a 9-0-ossina dotati di attivita' antibiotica

Publications (1)

Publication Number Publication Date
OA10491A true OA10491A (en) 2002-04-10

Family

ID=11369979

Family Applications (1)

Application Number Title Priority Date Filing Date
OA70023A OA10491A (en) 1994-12-13 1997-06-13 Erythromycin a 9-0-oxime derivatives endowed with antibiotic activity

Country Status (35)

Country Link
US (1) US5847092A (uk)
EP (1) EP0797579B1 (uk)
JP (1) JPH10510520A (uk)
KR (1) KR100367559B1 (uk)
CN (1) CN1046535C (uk)
AP (1) AP739A (uk)
AT (1) ATE190620T1 (uk)
AU (1) AU690791B2 (uk)
BG (1) BG63261B1 (uk)
BR (1) BR9510015A (uk)
CA (1) CA2207029A1 (uk)
CZ (1) CZ289943B6 (uk)
DE (1) DE69515694T2 (uk)
DK (1) DK0797579T3 (uk)
EE (1) EE03401B1 (uk)
ES (1) ES2144154T3 (uk)
FI (1) FI972493A (uk)
GE (1) GEP20012391B (uk)
GR (1) GR3033622T3 (uk)
HU (1) HU220631B1 (uk)
IT (1) IT1276901B1 (uk)
LT (1) LT4276B (uk)
LV (1) LV11898B (uk)
MD (1) MD1788G2 (uk)
NO (1) NO309816B1 (uk)
NZ (1) NZ297446A (uk)
OA (1) OA10491A (uk)
PL (1) PL182053B1 (uk)
PT (1) PT797579E (uk)
RO (1) RO116282B1 (uk)
RU (1) RU2152951C1 (uk)
SI (1) SI9520124A (uk)
TJ (1) TJ306B (uk)
UA (1) UA48958C2 (uk)
WO (1) WO1996018633A1 (uk)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1290447B1 (it) 1997-03-28 1998-12-03 Zambon Spa Derivati 1,3-ossatiolanici ad attivita' antivirale
IT1301967B1 (it) * 1998-07-30 2000-07-20 Zambon Spa Derivato di eritromicina ad attivita' antibiotica
IT1301968B1 (it) * 1998-07-30 2000-07-20 Zambon Spa Derivati di eritromicina ad attivita' antibiotica
IT1306205B1 (it) * 1999-01-15 2001-05-30 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
US6947844B2 (en) 2000-08-09 2005-09-20 Yale University Modulators of ribosomal function and identification thereof
US6638908B1 (en) 2000-08-09 2003-10-28 Yale University Crystals of the large ribosomal subunit
IL151012A0 (en) 2001-08-03 2003-02-12 Ribosomes Structure And Protei Ribosomes structure and protein synthesis inhibitors
US6952650B2 (en) 2001-08-03 2005-10-04 Yale University Modulators of ribosomal function and identification thereof
ITMI20021726A1 (it) 2002-08-01 2004-02-02 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
AR043050A1 (es) 2002-09-26 2005-07-13 Rib X Pharmaceuticals Inc Compuestos heterociclicos bifuncionales y metodos para preparar y usar los mismos
US8202843B2 (en) 2004-02-27 2012-06-19 Rib-X Pharmaceuticals, Inc. Macrocyclic compounds and methods of making and using the same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2473525A1 (fr) * 1980-01-11 1981-07-17 Roussel Uclaf Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments
GB8521402D0 (en) 1985-08-28 1985-10-02 Beecham Group Plc Chemical compounds
US4740502A (en) * 1986-06-20 1988-04-26 Abbott Laboratories Semisynthetic erythromycin antibiotics
EP0284203A3 (en) 1987-02-24 1989-11-02 Beecham Group Plc Erythromycin derivatives, process for their preparation and their pharmaceutical use
US5302705A (en) * 1989-10-07 1994-04-12 Taisho Pharmaceutical Co., Ltd. 6-O-methylerythromycin a oxime derivatives
IL114589A (en) * 1990-11-21 1999-12-22 Roussel Uclaf Intermediates for the preparation of the history of erythromycin

Also Published As

Publication number Publication date
NO972702D0 (no) 1997-06-12
RO116282B1 (ro) 2000-12-29
PL182053B1 (pl) 2001-10-31
NZ297446A (en) 1999-06-29
GR3033622T3 (en) 2000-10-31
CZ289943B6 (cs) 2002-04-17
CN1169727A (zh) 1998-01-07
DK0797579T3 (da) 2000-06-05
PT797579E (pt) 2000-08-31
ITMI942496A0 (it) 1994-12-13
PL320688A1 (en) 1997-10-27
JPH10510520A (ja) 1998-10-13
FI972493A0 (fi) 1997-06-12
IT1276901B1 (it) 1997-11-03
FI972493A (fi) 1997-06-12
EE03401B1 (et) 2001-04-16
DE69515694D1 (de) 2000-04-20
MX9704253A (es) 1997-09-30
UA48958C2 (uk) 2002-09-16
LV11898B (en) 1998-03-20
NO972702L (no) 1997-08-13
MD1788F2 (en) 2001-11-30
MD1788G2 (ro) 2002-05-31
WO1996018633A1 (en) 1996-06-20
BG101570A (en) 1998-02-27
KR100367559B1 (ko) 2003-04-21
AU690791B2 (en) 1998-04-30
BR9510015A (pt) 1997-10-28
DE69515694T2 (de) 2000-10-26
CN1046535C (zh) 1999-11-17
EP0797579B1 (en) 2000-03-15
NO309816B1 (no) 2001-04-02
GEP20012391B (en) 2001-03-25
AP739A (en) 1999-03-24
TJ306B (en) 2001-08-06
AU4260396A (en) 1996-07-03
HU220631B1 (hu) 2002-03-28
HUT77126A (hu) 1998-03-02
CZ178697A3 (en) 1997-12-17
BG63261B1 (bg) 2001-07-31
AP9700989A0 (en) 1997-07-31
MD970243A (en) 1999-05-31
LT4276B (lt) 1998-01-26
US5847092A (en) 1998-12-08
EE9700124A (et) 1997-12-15
CA2207029A1 (en) 1996-06-20
EP0797579A1 (en) 1997-10-01
RU2152951C1 (ru) 2000-07-20
ATE190620T1 (de) 2000-04-15
ES2144154T3 (es) 2000-06-01
LT97116A (en) 1997-10-27
SI9520124A (sl) 1998-04-30
ITMI942496A1 (it) 1996-06-13
LV11898A (lv) 1997-12-20

Similar Documents

Publication Publication Date Title
AU661585B2 (en) 5-0-desosaminylerythronolide A derivative
US4512982A (en) 9α-Aza-9α-homoerythromycin compounds, pharmaceutical composition and therapeutic method
EP1529053B1 (en) Macrolide compounds endowed with antiinflammatory activity
EP0159856B1 (en) 9a-aza-9a-homoerythromycin derivatives
HU193886B (en) Process for preparing epimer azahomoerythromycin a derivatives
HU221803B1 (hu) Azitromicin A O-benziloxi-karbonil-származék és savaddíciós sói
FR2745290A1 (fr) Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
OA10491A (en) Erythromycin a 9-0-oxime derivatives endowed with antibiotic activity
JPS58159499A (ja) 抗菌剤として有用な４″−エピエリスロマイシンａおよびその誘導体
JPH0142275B2 (uk)
DE602004010110T2 (de) Neue 14- und 15-gliedrige ringverbindungen
EP1100806B1 (en) Erythromycin derivative with antibiotic activity
MXPA97004253A (en) Derivatives of 9-0-oxima of erythromycin or dotated with antibioot activity
WO2005108413A1 (en) Carbamate linked macrolides useful for the treatment of microbial infections
KR20050085555A (ko) 아잘라이드 계열의 신규한 반합성 마크로라이드 항생제
Bright et al. Synthesis and biological activities of 4"-deoxy-4"-sulfonamido-oleandomycin derivatives
JPH05194577A (ja) １０，１１，１２，１３−テトラヒドロ−デスマイコシン誘導体、その製造法及びその医薬としての用途
FR2614894A1 (fr) Nouvelles oximes derivees de la tylosine, leur procede de preparation et les compositions pharmaceutiques les contenant